Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

NCT00645021 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Hepatic Insufficiency

Interventions

DRUG: CP-945,598
DRUG: CP-945,598
DRUG: CP-945,598

Sponsor

Pfizer